WHO ICTRP trial
Active smoking and bronchodilator treatment in patients with chronic obstructive…
NL-OMON33894 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON33894 |
|---|---|
| Public title | Active smoking and bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD): a hazardous combination in causing cardiovascular disease? |
| Scientific title | Active smoking and bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD): a hazardous combination in causing cardiovascular disease? - Interaction in COPD Experiment (ICE) |
| Primary sponsor | Universitair Medisch Centrum Sint Radboud |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | cardiovascular disease emphysema heart disease. chronic obstructive pulmonary disease;10082206;10006436;10003216;cardiovascular disease;emphysema;heart disease. chronic obstructive pulmonary disease |
| Interventions | Patients recieve whether a bronchodilator or a placebo twice, preceded and followed by repeatedly inhaling cigarette smoke during two hours as by a strict time schedule. ;bronchodilators;cardiovascular disease;COPD;smoking |
| Registration date | May 20, 2009 |
| Target size | 50 |
| Secondary IDs | NL25227.091.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: